Sustainable Development - Our Commitment
View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better.
Search
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.
Speak up
We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Find out more.
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term. Click here to learn more.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
The Nagoya Protocol
At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do. Read our commitments to the Nagoya Protocol.
Protecting Animals and Humans
At Boehringer Ingelheim we are committed to ensuring the continued availability of our products for patients, customers and animals during the pandemic.
COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. Learn about how we collaborate with patient organisations.
MORE GREEN: Environmental sustainability at a glance
On Earth Day, we share the progress of our global environmental sustainability MORE GREEN program and what the team is tackling, all 365 days of the year.
More Potential
Continuing a journey that began more than 135 years ago, Boehringer Ingelheim steps up its commitment to sustainable development. Find out more here.
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
More Potential Overview
More Potential works to provide the best conditions for our people, communities and partners along our value chain. Click here to find out more.
Our Ambition 2025
Boehringer Ingelheim’s commitment to serve humankind can be met if we are the preferred partner and admired competitor in three areas. Learn more here.
COVID-19 France Support to Pasteur Institute
As part of our Global Donation Program, we are supporting research on COVID-19 in France. Click here to learn more information about the support.
COVID-19 France Production of hydroalcoholic-gel
We have launched production of our first hydro-alcoholic solution for internal use to help battle COVID-19. Click here to find out and learn more.
Commits to Thoracic Society’s COVID-19 Fund
Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
Resizing our Carbon Footprint
The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
Purchasing
Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too.
Accessibility Statement
Boehringer Ingelheim prides itself on being accessible to our audience. Click here to see how we are making our website as user friendly as possible.
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach is a herculean task – but also an innovation that carries huge potential. Learn more here.
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity; a key element of our culture. Click here to find out more information.